Valuation: PolyNovo Limited

Market Cap 63Cr 43Cr 39Cr 36Cr 32Cr 61Cr 4.02TCr 427.55Cr 170.41Cr 2.15TCr 160.79Cr 157.37Cr 6.85TCr P/E 2027 *
64.2x
P/E 2028 * 33.8x
Enterprise Value 59Cr 40Cr 36Cr 33Cr 30Cr 57Cr 3.76TCr 400.16Cr 159.49Cr 2.01TCr 150.49Cr 147.29Cr 6.41TCr EV / Sales 2027 *
3.62x
EV / Sales 2028 * 3.07x
Free-Float
90.03%
Yield 2027 *
-
Yield 2028 * -
1 day+2.26%
1 week-2.16%
1 month-3.21%
3 months-4.23%
6 months-10.40%
Current year-26.42%
1 week 0.88
Extreme 0.875
0.94
1 month 0.84
Extreme 0.84
0.96
Current year 0.81
Extreme 0.81
1.3
1 year 0.81
Extreme 0.81
1.3
3 years 0.81
Extreme 0.81
2.78
5 years 0.81
Extreme 0.81
2.78
10 years 0.17
Extreme 0.17
4.08
Manager TitleAgeSince
Chief Executive Officer - 01/12/2025
Director of Finance/CFO - 12/12/2018
Chief Tech/Sci/R&D Officer - 01/06/2026
Director TitleAgeSince
Chairman - 27/10/2025
Director/Board Member 48 04/06/2021
Director/Board Member 66 14/10/2025
Date Insider Type Main position Quantity % Market Cap. Importance
16/03/26 Buy

Director

1,51,000 0.0219%
27/02/26 Buy

Director

1,00,000 0.0145%
27/02/26 Buy

Chairman

30,000 0.0043%
Change 5-day change 1-year change 3-year change Capi.($)
+2.26%-2.16%-26.12%-34.18% 42Cr
-0.52%-4.65%-13.28%+14.98% 19TCr
-0.64%-3.64%+6.02%+40.32% 12TCr
-1.91%-6.13%-12.34%+13.12% 12TCr
-2.69%-3.46%-42.12%+3.28% 9.61TCr
-0.42%-1.92%-4.89%+74.60% 6.65TCr
-0.28%+1.29%+12.09%-10.17% 5.79TCr
+0.06%+0.08%-1.88%+61.68% 5.49TCr
+1.47%-3.69%-4.56%+55.85% 4.91TCr
-3.88%-6.01%-3.60%-9.36% 3.62TCr
Average -0.71%+1.72%-9.07%+21.01% 8TCr
Weighted average by Cap. -1.00%+2.37%-9.32%+24.94%

Financials

2027 *2028 *
Net sales 16Cr 11Cr 9.99Cr 9.23Cr 8.34Cr 16Cr 1.04TCr 110.63Cr 44Cr 556.85Cr 42Cr 41Cr 1.77TCr 19Cr 13Cr 11Cr 11Cr 9.58Cr 18Cr 1.19TCr 126.99Cr 51Cr 639.18Cr 48Cr 47Cr 2.03TCr
Net income 97.73L 66.97L 60.36L 55.77L 50.41L 95.38L 63Cr 6.68Cr 2.66Cr 34Cr 2.51Cr 2.46Cr 107.05Cr 1.85Cr 1.27Cr 1.14Cr 1.06Cr 95.41L 1.81Cr 118.88Cr 13Cr 5.04Cr 64Cr 4.76Cr 4.66Cr 202.62Cr
Net Debt -4.01Cr -2.74Cr -2.47Cr -2.29Cr -2.07Cr -3.91Cr -257.44Cr -27Cr -11Cr -137.88Cr -10Cr -10Cr -438.77Cr -5.53Cr -3.79Cr -3.42Cr -3.16Cr -2.85Cr -5.4Cr -355.58Cr -38Cr -15Cr -190.43Cr -14Cr -14Cr -606.02Cr
Projected Income Statement - Annual - PolyNovo Limited
Logo PolyNovo Limited
PolyNovo Limited is an Australia-based medical technology company. The Company’s business includes designing, manufacturing and selling biomedical devices. Its principal activity is the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture medical devices designed to support tissue repair. NovoSorb polymer devices can be expressed in a variety of physical formats including foam, coatings, fibers, plastic structures, films, and biologic carriers. Its products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a bilayer dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma or burn. NovoSorb MTX has applicability for single stage grafting in burns, chronic, and surgical wounds.
Employees
301
Date Price Change Volume
11/26/11 A$0.9050 +2.26% 6,40,882
10/26/10 A$0.8850 -2.75% 9,68,354
09/26/09 A$0.9100 +2.25% 4,88,618
06/26/06 A$0.8900 -1.66% 10,62,626
05/26/05 A$0.9050 +3.43% 15,24,680
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - PolyNovo Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
0.9050AUD
Average target price
1.254AUD
Spread / Average Target
+38.57%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PolyNovo Limited